Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/12436
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorGRANGEIRO, Alexandre-
dc.contributor.authorCOUTO, Marcia Thereza-
dc.contributor.authorPERES, Maria Fernanda-
dc.contributor.authorLUIZ, Olinda-
dc.contributor.authorZUCCHI, Eliana Miura-
dc.contributor.authorCASTILHO, Euclides Ayres de-
dc.contributor.authorESTEVAM, Denize Lotufo-
dc.contributor.authorALENCAR, Rosa-
dc.contributor.authorWOLFFENBUETTEL, Karina-
dc.contributor.authorESCUDER, Maria Mercedes-
dc.contributor.authorCALAZANS, Gabriela-
dc.contributor.authorFERRAZ, Dulce-
dc.contributor.authorARRUDA, Erico-
dc.contributor.authorCORREA, Maria da Gloria-
dc.contributor.authorAMARAL, Fabiana Rezende-
dc.contributor.authorSANTOS, Juliane Cardoso Villela-
dc.contributor.authorALVAREZ, Vivian Salles-
dc.contributor.authorKIETZMANN, Tiago-
dc.date.accessioned2015-12-10T16:49:18Z-
dc.date.available2015-12-10T16:49:18Z-
dc.date.issued2015-
dc.identifier.citationBMJ OPEN, v.5, n.8, article ID e009021, 11p, 2015-
dc.identifier.issn2044-6055-
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/12436-
dc.description.abstractIntroduction: Few results from programmes based on combination prevention methods are available. We propose to analyse the degree of protection provided by postexposure prophylaxis (PEP) for consensual sexual activity at healthcare clinics, its compensatory effects on sexual behaviour; and the effectiveness of combination prevention methods and pre-exposure prophylaxis (PrEP), compared with exclusively using traditional methods. Methods and analysis: A total of 3200 individuals aged 16 years or older presenting for PEP at 5 sexually transmitted disease (STD)/HIV clinics in 3 regions of Brazil will be allocated to one of two groups: the PEP group-individuals who come to the clinic within 72 h after a sexual exposure and start PEP; and the non-PEP group-individuals who come after 72 h but within 30 days of exposure and do not start PEP. Clinical follow-up will be conducted initially for 6 months and comprise educational interventions based on information and counselling for using prevention methods, including PrEP. In the second study phase, individuals who remain HIV negative will be regrouped according to the reported use of prevention methods and observed for 18 months: only traditional methods; combined methods; and PrEP. Effectiveness will be analysed according to the incidence of HIV, syphilis and hepatitis B and C and protected sexual behaviour. A structured questionnaire will be administered to participants at baseline and every 6 months thereafter. Qualitative methods will be employed to provide a comprehensive understanding of PEP-seeking behaviour, preventive choices and exposure to HIV. Ethics and dissemination: This study will be conducted in accordance with the resolution of the School of Medicine Research Ethics Commission of Universidade de Sao Paulo (protocol no. 251/14). The databases will be available for specific studies, after management committee approval. Findings will be presented to researchers, health managers and civil society members by means of newspapers, electronic media and scientific journals and meetings.-
dc.description.sponsorshipBrazilian Ministry of Health [SVS-MS 01-2012, 027941/2012]-
dc.description.sponsorshipNational Council for Scientific and Technological Development [MCTI/CNPQ/UNIVERSAL 14/2014]-
dc.language.isoeng-
dc.publisherBMJ PUBLISHING GROUP-
dc.relation.ispartofBMJ Open-
dc.rightsopenAccess-
dc.subject.othersexual risk behavior-
dc.subject.otherhomosexual-men-
dc.subject.otherfollow-up-
dc.subject.othergay men-
dc.subject.otherantiretroviral therapy-
dc.subject.otherheterosexual men-
dc.subject.otherexposure-
dc.subject.othercohort-
dc.subject.otherinfection-
dc.subject.othertransmission-
dc.titlePre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil-
dc.typearticle-
dc.rights.holderCopyright BMJ PUBLISHING GROUP-
dc.identifier.doi10.1136/bmjopen-2015-009021-
dc.identifier.pmid26307622-
dc.subject.wosMedicine, General & Internal-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-
hcfmusp.author.externalZUCCHI, Eliana Miura:Univ Catolica Santos, Programa Posgrad Saude Colet, Sao Paulo, Brazil-
hcfmusp.author.externalESTEVAM, Denize Lotufo:Secretaria Estado Saude Sao Paulo, Ctr Referencia & Treinamento DST Aids, Sao Paulo, Brazil-
hcfmusp.author.externalALENCAR, Rosa:Secretaria Estado Saude Sao Paulo, Ctr Referencia & Treinamento DST Aids, Sao Paulo, Brazil-
hcfmusp.author.externalWOLFFENBUETTEL, Karina:Secretaria Estado Saude Sao Paulo, Ctr Referencia & Treinamento DST Aids, Sao Paulo, Brazil-
hcfmusp.author.externalESCUDER, Maria Mercedes:Secretaria Estado Saude Sao Paulo, Inst Saude, Sao Paulo, Brazil-
hcfmusp.author.externalARRUDA, Erico:Secretaria Estado Saude Ceara, Hosp Sao Jose, Fortaleza, Ceara, Brazil-
hcfmusp.author.externalCORREA, Maria da Gloria:Secretaria Municipal Saude Porto Alegre, Serv Atendimento Especializado Doencas Sexualment, Porto Alegre, RS, Brazil-
hcfmusp.author.externalAMARAL, Fabiana Rezende:Secretaria Municipal Saude Ribeirao Preto, Ctr Referencia Especialidades Cent, Ribeirao Preto, Brazil-
hcfmusp.author.externalSANTOS, Juliane Cardoso Villela:Secretaria Municipal Saude Curitiba, Ctr Orientacao & Aconselhamento, Curitiba, Parana, Brazil-
hcfmusp.description.articlenumbere009021-
hcfmusp.description.issue8-
hcfmusp.description.volume5-
hcfmusp.origemWOS-
hcfmusp.origem.idWOS:000363479100081-
hcfmusp.origem.id2-s2.0-84941559284-
hcfmusp.publisher.cityLONDON-
hcfmusp.publisher.countryENGLAND-
hcfmusp.relation.referenceWong K, 2010, INT J STD AIDS, V21, P617, DOI 10.1258/ijsa.2008.008482-
hcfmusp.relation.referencePoynten IM, 2007, HIV MED, V8, P374, DOI 10.1111/j.1468-1293.2007.00483.x-
hcfmusp.relation.referenceMehta SA, 2011, SEX TRANSM INFECT, V87, P344, DOI 10.1136/sti.2010.046284-
hcfmusp.relation.referenceKippax S, 1998, AIDS CARE, V10, P677, DOI 10.1080/09540129848307-
hcfmusp.relation.referenceCurran JW, 2013, AM J PREV MED, V44, pS163, DOI 10.1016/j.amepre.2012.10.005-
hcfmusp.relation.referenceGrant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3-
hcfmusp.relation.referenceLunding S, 2010, SEX TRANSM DIS, V37, P49, DOI 10.1097/OLQ.0b013e3181b6f284-
hcfmusp.relation.referenceCardo DM, 1997, NEW ENGL J MED, V337, P1485, DOI 10.1056/NEJM199711203372101-
hcfmusp.relation.referenceHeuker J, 2012, AIDS, V26, P505, DOI 10.1097/QAD.0b013e32834f32d8-
hcfmusp.relation.referenceChang LW, 2013, LANCET INFECT DIS, V13, P65, DOI 10.1016/S1473-3099(12)70273-6-
hcfmusp.relation.referenceShoptaw S, 2008, AIDS CARE, V20, P376, DOI 10.1080/09540120701660353-
hcfmusp.relation.referenceHarris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010-
hcfmusp.relation.referenceRey D, 2000, AIDS CARE, V12, P695, DOI 10.1080/09540120020014228-
hcfmusp.relation.referenceZablotska IB, 2011, JAIDS-J ACQ IMM DEF, V58, P424, DOI 10.1097/QAI.0b013e318230e885-
hcfmusp.relation.referenceHart GJ, 2010, CURR OPIN INFECT DIS, V23, P39, DOI 10.1097/QCO.0b013e328334feb1-
hcfmusp.relation.referenceBentz L, 2010, AIDS CARE, V22, P1509, DOI 10.1080/09540121.2010.484457-
hcfmusp.relation.referenceDonnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2-
hcfmusp.relation.referenceCohen MS, 2011, NEW ENGL J MED, V365, P493, DOI 10.1056/NEJMoa1105243-
hcfmusp.relation.referenceKorner H, 2006, AIDS CARE, V18, P879, DOI 10.1080/09540120500307909-
hcfmusp.relation.referenceLandovitz RJ, 2009, NEW ENGL J MED, V361, P1768, DOI 10.1056/NEJMcp0904189-
hcfmusp.relation.referenceJin FY, 2009, AIDS, V23, P243, DOI 10.1097/QAD.0b013e32831fb51a-
hcfmusp.relation.referenceBrooks RA, 2012, AIDS PATIENT CARE ST, V26, P87, DOI 10.1089/apc.2011.0283-
hcfmusp.relation.referenceArmishaw J, 2011, INT J STD AIDS, V22, P714, DOI 10.1258/ijsa.2011.011174-
hcfmusp.relation.referenceBaeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524-
hcfmusp.relation.referencePadian NS, 2011, LANCET, V378, P269, DOI 10.1016/S0140-6736(11)60877-5-
hcfmusp.relation.referencePoynten IM, 2009, AIDS, V23, P1119, DOI 10.1097/QAD.0b013e32832c1776-
hcfmusp.relation.referenceSperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201-
hcfmusp.relation.referenceMartin JN, 2004, AIDS, V18, P787, DOI 10.1097/01.aids.0000111465.61782.2d-
hcfmusp.relation.referenceCohen SE, 2013, AM J PREV MED, V44, pS80, DOI 10.1016/j.amepre.2012.09.036-
hcfmusp.relation.referenceIrvine C, 2015, CLIN INFECT DIS, V60, pS165, DOI 10.1093/cid/civ069-
hcfmusp.relation.referenceMugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3-
hcfmusp.relation.referenceLiu AY, 2013, JAIDS-J ACQ IMM DEF, V64, P87, DOI 10.1097/QAI.0b013e31828f097a-
hcfmusp.relation.referencePrestage G, 2013, AIDS BEHAV, V17, P1352, DOI 10.1007/s10461-012-0180-7-
hcfmusp.relation.referenceSchechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010-
hcfmusp.relation.referenceThigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711-
hcfmusp.relation.referenceBryant J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13140-
hcfmusp.relation.referenceBaber TJ, 2010, CURR OPIN HIV AIDS, V5, P322-
hcfmusp.relation.referenceBalbuena SF, 2013, HIV MED, V14, P252-
hcfmusp.relation.referenceBrasil. Ministerio da Saude, 2013, PROT CLIN DIR TER AD-
hcfmusp.relation.referenceBrasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Programa Nacional de DST e Aids, 2010, REC TER ANT AD INF P-
hcfmusp.relation.referenceSmith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65-
hcfmusp.relation.referenceDamme LV, 2012, NEW ENGL J MED, V367, P411-
hcfmusp.relation.referenceGrant RM, 2010, NEW ENGL J MED, V363, P2787-
hcfmusp.relation.referenceJoint United Nation Programme on HIV/AIDS, 2010, COMB HIV PREV TAIL C-
hcfmusp.relation.referenceKennedy C, 2014, PREEXPOSURE PROPHYLA-
hcfmusp.relation.referenceKrakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119-
hcfmusp.relation.referenceKurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3-
hcfmusp.relation.referenceMcConnell JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008831-
hcfmusp.relation.referenceMcCormack S, 2015, C RETR OPP INF-
hcfmusp.relation.referenceMeyer-Rath G, 2012, PLOS MED, V9, P1-
hcfmusp.relation.referenceMicrobicide Trials Network, UND RES VOIC FACT SH-
hcfmusp.relation.referenceMinas B, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-906-
hcfmusp.relation.referenceMolina J, 2015, C RETR VIR OPP INF-
hcfmusp.relation.referenceOldenburg CE, 2014, AIDS BEHAV, V18, P217, DOI 10.1007/s10461-013-0567-0-
hcfmusp.relation.referenceParker R., 2011, BROWN J WORLD AFFAIR, V17, P21-
hcfmusp.relation.referenceSilverman D, 2011, HDB QUALITATIVE RES, P821-
hcfmusp.relation.referenceSineath R Craig, 2013, J Int Assoc Provid AIDS Care, V12, P227, DOI 10.1177/2325957413488184-
hcfmusp.relation.referenceSmith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1-
hcfmusp.relation.referenceThe Consensus Committee Southern African HIV Clinicians Society, 2012, SAJHIVMED, V2, P40-
hcfmusp.relation.referenceThe International AIDS Society, 2012, INT AIDS C U CAL SAN-
hcfmusp.relation.referenceTissot F, 2010, HIV MED, V11, P584, DOI 10.1111/j.1468-1293.2010.00826.x-
hcfmusp.relation.referenceVieira E M, 2000, Cad Saude Publica, V16, P997, DOI 10.1590/S0102-311X2000000400018-
hcfmusp.relation.referenceWeller SC, 2007, CONDOM EFFECTIVENESS-
hcfmusp.relation.referenceWorld Health Organization, 2012, STRAT US ANT HELP EN-
hcfmusp.relation.referenceWorld Health Organization, 2012, PROGR UPD ANT TREATM-
dc.description.indexMEDLINE-
hcfmusp.citation.scopus19-
hcfmusp.scopus.lastupdate2024-03-29-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MPR
Departamento de Medicina Preventiva - FM/MPR

Artigos e Materiais de Revistas Científicas - LIM/38
LIM/38 - Laboratório de Epidemiologia e Imunobiologia

Artigos e Materiais de Revistas Científicas - LIM/39
LIM/39 - Laboratório de Processamento de Dados Biomédicos

Artigos e Materiais de Revistas Científicas - ODS/03
ODS/03 - Saúde e bem-estar

Artigos e Materiais de Revistas Científicas - ODS/05
ODS/05 - Igualdade de gênero


Files in This Item:
File Description SizeFormat 
art_GRANGEIRO_Preexposure_and_postexposure_prophylaxes_and_the_combination_HIV_2015.PDFpublishedVersion (English)1.33 MBAdobe PDFThumbnail
View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.